Get the Stockscreener App
12.18
0.65%
-0.08
Atara Biotherapeutics Inc Stock (ATRA) Forecast
The Atara Biotherapeutics Inc (ATRA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.0115, representing a -26.01% decrease from the current price of $12.18. The highest analyst price target is $9.1503, and the lowest is $8.8726.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATRA Price Target
Average 8.5097
(-30.13% Downside)
Is Atara Biotherapeutics Inc (ATRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.24 | Neutral |
| STOCH(9,6) | 36.19 | Neutral |
| STOCHRSI(14) | 32.74 | Neutral |
| MACD(12,26) | 0.6968 | Sell |
| ADX(14) | 38.88 | Buy |
| William %R | -56.01 | Neutral |
| CCI(14) | 40.42 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.64
Buy
|
11.67
Buy
|
| MA20 |
11.30
Buy
|
11.18
Buy
|
| MA50 |
9.4582
Buy
|
10.14
Buy
|
| MA100 |
9.1119
Buy
|
10.31
Buy
|
| MA200 |
12.32
Sell
|
13.70
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, ATRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ATRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.24 indicates that ATRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 36.19 indicates that ATRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 32.74 indicates that ATRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.88 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 40.42 indicates that ATRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ATRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atara Biotherapeutics Inc financial reports and earnings history, Atara Biotherapeutics Inc (ATRA) stock could reach $27.12 by 2030, $15.36 by 2040 and $47.72 by 2050. See the projected annual prices until 2050 of the Atara Biotherapeutics Inc stock below:
- Atara Biotherapeutics Inc (ATRA) is expected to reach an average price of $5.3763 in 2035, with a high prediction of $5.5817 and a low estimate of $5.3611. This indicates an $-55.86% rise from the last recorded price of $12.18.
- Atara Biotherapeutics Inc (ATRA) stock is projected to chart a bullish course in 2040, with an average price target of $14.88, representing an $22.20% surge from its current level. The forecast ranges from a conservative $15.13 to a sky-high $15.36.
- Our analysts predict Atara Biotherapeutics Inc (ATRA) to jump 152.10% by 2045, soaring from $30.88 to an average price of $30.71, potentially reaching $31.20. While $30.88 is the low estimate, the potential upside is significant.
- Atara Biotherapeutics Inc (ATRA) stock is expected to climb by 2050, reaching an average of $47.20, a $287.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.72 and $45.62, respectively, highlighting the market's uncertainty.
Atara Biotherapeutics Inc Stock (ATRA) Year by Year Forecast
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2024
Our forecast for ATRA stock price in 2024 now indicates an average price target of $5.8184 with a high forecast of $11.20 and a low forecast of $0.4323. The average prediction reflects an decrease of -52.23% from the last recorded price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $8.5138 | $8.8726 | $9.1503 | -30.10% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2025
Atara Biotherapeutics Inc Stock (ATRA) is expected to reach an average price of $8.5097 in 2025, with a high prediction of $13.09 and a low estimate of $3.9321. This indicates an -30.13% fall from the last recorded price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.1046 | $6.2434 | $6.2311 | -49.88% |
| February, 2025 | $8.5742 | $6.5357 | $7.3742 | -29.60% |
| March, 2025 | $9.7039 | $8.3565 | $8.7889 | -20.33% |
| April, 2025 | $12.73 | $9.385 | $13.09 | +4.51% |
| May, 2025 | $12.54 | $12.54 | $12.49 | +2.99% |
| June, 2025 | $9.6039 | $11.01 | $12.51 | -21.15% |
| July, 2025 | $9.2197 | $9.2012 | $9.1567 | -24.30% |
| August, 2025 | $4.9244 | $5.1444 | $5.7759 | -59.57% |
| September, 2025 | $6.549 | $6.0567 | $5.719 | -46.23% |
| October, 2025 | $5.9498 | $5.4736 | $6.1052 | -51.15% |
| November, 2025 | $5.5644 | $3.9321 | $5.1444 | -54.31% |
| December, 2025 | $5.1952 | $4.7591 | $4.7506 | -57.35% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2026
The predicted value for Atara Biotherapeutics Inc (ATRA) in 2026 is set at an average of $5.3643. Estimates vary from a peak of $10.68 to a trough of $0.047, indicating an -55.96% surge from the present price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5001 | $1.1263 | $6.2301 | -54.84% |
| February, 2026 | $4.2055 | $4.0155 | $10.68 | -65.47% |
| March, 2026 | $1.5108 | $1.2408 | $5.7393 | -87.60% |
| April, 2026 | $1.20 | $0.3847 | $5.0862 | -90.15% |
| May, 2026 | $1.3046 | $0.3861 | $1.6554 | -89.29% |
| June, 2026 | $2.2392 | $1.7731 | $1.3869 | -81.62% |
| July, 2026 | $0.60 | $1.7477 | $1.5654 | -95.07% |
| August, 2026 | $0.8547 | $1.7562 | $1.3024 | -92.98% |
| September, 2026 | $0.6855 | $0.047 | $1.8468 | -94.37% |
| October, 2026 | $1.8601 | $1.5516 | $1.3801 | -84.73% |
| November, 2026 | $0.8152 | $0.4752 | $1.4224 | -93.31% |
| December, 2026 | $4.1844 | $0.5829 | $4.6044 | -65.64% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atara Biotherapeutics Inc (ATRA) is $3.4521, with a high forecast of $6.7975 and a low forecast of $0.1066. This indicates an -71.66% decrease from the last price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6198 | $0.9998 | $4.516 | -78.49% |
| February, 2027 | $5.2252 | $1.5536 | $6.7975 | -57.10% |
| March, 2027 | $2.4944 | $2.1144 | $5.859 | -79.52% |
| April, 2027 | $3.7497 | $1.6097 | $5.2621 | -69.21% |
| May, 2027 | $2.6251 | $0.9474 | $4.1974 | -78.45% |
| June, 2027 | $2.7157 | $0.1066 | $4.1689 | -77.70% |
| July, 2027 | $1.9403 | $2.0842 | $1.7919 | -84.07% |
| August, 2027 | $3.635 | $1.9965 | $2.745 | -70.16% |
| September, 2027 | $5.2658 | $4.3373 | $5.1458 | -56.77% |
| October, 2027 | $4.2704 | $5.1943 | $5.1519 | -64.94% |
| November, 2027 | $1.3051 | $1.7751 | $2.3766 | -89.29% |
| December, 2027 | $3.5459 | $5.8659 | $6.2035 | -70.89% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2028
In 2028, Atara Biotherapeutics Inc (ATRA) is projected to reach an average price of $3.5094, with a high projection of $4.9743 and a low estimate of $2.0445. This indicates an -71.19% fall from the last price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.7605 | $4.902 | $4.9743 | -60.92% |
| February, 2028 | $4.9351 | $4.8617 | $4.804 | -59.48% |
| March, 2028 | $3.6359 | $3.7357 | $4.4013 | -70.15% |
| April, 2028 | $3.7806 | $3.7121 | $3.4906 | -68.96% |
| May, 2028 | $4.5514 | $3.3541 | $3.7664 | -62.63% |
| June, 2028 | $3.316 | $3.701 | $4.1775 | -72.77% |
| July, 2028 | $2.6107 | $2.0445 | $1.8222 | -78.57% |
| August, 2028 | $3.6215 | $2.6191 | $2.8415 | -70.27% |
| September, 2028 | $3.3461 | $3.4061 | $3.1599 | -72.53% |
| October, 2028 | $2.8707 | $3.2784 | $3.2548 | -76.43% |
| November, 2028 | $3.8215 | $3.5969 | $3.7965 | -68.62% |
| December, 2028 | $3.4162 | $3.3239 | $3.2762 | -71.95% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2029
The 2029 price forecast for Atara Biotherapeutics Inc Stock (ATRA) is $7.0884 on average, with a high prediction of $14.11 and a low estimate of $0.0658. This represents an -41.80% decrease from the previous price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.397 | $2.507 | $3.0823 | -80.32% |
| February, 2029 | $2.8516 | $2.5231 | $2.7116 | -76.59% |
| March, 2029 | $2.4062 | $2.4662 | $2.6078 | -80.24% |
| April, 2029 | $2.0609 | $2.2709 | $2.1447 | -83.08% |
| May, 2029 | $2.9519 | $2.0955 | $1.9994 | -75.76% |
| June, 2029 | $2.1985 | $2.2744 | $2.4838 | -81.95% |
| July, 2029 | $1.9982 | $2.0019 | $2.0456 | -83.59% |
| August, 2029 | $1.4682 | $1.5232 | $1.8778 | -87.95% |
| September, 2029 | $1.0201 | $1.0201 | $0.9698 | -91.62% |
| October, 2029 | $0.6398 | $0.7466 | $0.7587 | -94.75% |
| November, 2029 | $0.3408 | $0.3617 | $0.5034 | -97.20% |
| December, 2029 | $24.63 | $0.0658 | $14.11 | +102.22% |
Atara Biotherapeutics Inc Stock (ATRA) Price Forecast for 2030
Atara Biotherapeutics Inc Stock (ATRA) is expected to reach an average price of $30.85 in 2030, with a high forecast of $34.84 and a low forecast of $26.85. This signifies an +153.27% surge from the last price of $12.18.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.87 | $26.85 | $27.12 | +128.84% |
| February, 2030 | $30.69 | $29.02 | $29.40 | +151.99% |
| March, 2030 | $35.53 | $34.41 | $34.01 | +191.72% |
| April, 2030 | $34.29 | $34.92 | $34.84 | +181.49% |
| May, 2030 | $32.84 | $33.16 | $33.27 | +169.64% |
| June, 2030 | $33.96 | $33.58 | $33.08 | +178.83% |
| July, 2030 | $31.62 | $32.30 | $33.75 | +159.63% |
| August, 2030 | $29.47 | $30.33 | $30.89 | +141.97% |
| September, 2030 | $27.48 | $28.43 | $27.83 | +125.63% |
| October, 2030 | $28.90 | $28.90 | $29.17 | +137.26% |
| November, 2030 | $34.73 | $29.97 | $30.36 | +185.16% |
| December, 2030 | $34.53 | $33.91 | $34.29 | +183.51% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):